Barclays Initiates Coverage of the U.S. Medical Technology Sector and Says Valuations Have Reached a Ten-Year Low Life Science
Option Care Health Receives $5.8 Billion Acquisition Offer, Stock Price Soars 33% in a Single Day Life Science
Pfizer’s High Dividend Is Undervalued by the Market, and Investors May Be Facing a Good Opportunity to Position Themselves Life Science
Johnson & Johnson Maintains Steady Dividends While Eli Lilly Bets on the Weight-Loss Drug Track Life Science
Lilly and Viking Just Showed the Obesity Market’s Next Phase — and It’s Not About Pounds Life Science
